Civica Rx and Exela Pharma Sciences Join Forces to Provide Sodium Bicarbonate to Hospitals Across the U.S.
Civica Rx (Civica, Inc.) and Exela Pharma Sciences, LLC (Exela), today announce a long-term agreement to manufacture and supply Civica's growing membership of U.S. health systems with sodium bicarbonate injection, which has been in critically short supply in U.S. hospitals.
- Civica Rx (Civica, Inc.) and Exela Pharma Sciences, LLC (Exela), today announce a long-term agreement to manufacture and supply Civica's growing membership of U.S. health systems with sodium bicarbonate injection, which has been in critically short supply in U.S. hospitals.
- Civica member hospitals have prioritized sodium bicarbonate as an urgent medical need because theyve had to ration use of the medication due to ongoing shortages.
- Under the agreement, Exela will produce sodium bicarbonate for Civica, using Exelas Abbreviated New Drug Application (ANDA) and Civica's labeling and National Drug Code (NDC).
- Sodium bicarbonate is a medicine that is a staple on hospital crash carts and often used for emergency resuscitations.